Details of the Drug Reposition

General Information of This Drug (ID: DMCGPU8)

Drug Name
SNX281   DMCGPU8
Drug Type
Small molecular drug

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1 [1]
Lymphoma DISN6V4S 2A80-2A86 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04609579) Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma. U.S. National Institutes of Health.